Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study.
- 14 May 2001
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 47 (5) , 404-410
- https://doi.org/10.1007/s002800000257
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: